Open AccessLiver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy
Author(s) -
Evan Lehrman,
Nicholas Fidelman
Publication year - 2020
Publication title -
seminars in interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 40
eISSN - 1098-8963
pISSN - 0739-9529
DOI - 10.1055/s-0040-1720951
Subject(s) - radionuclide therapy , medicine , peptide receptor , perioperative , systemic therapy , neuroendocrine tumors , medical therapy , radiology , receptor , cancer , breast cancer
Neuroendocrine tumor liver metastases are treated by a multidisciplinary cohort of physicians that work together to achieve optimal clinical results for their patients. This review addresses critical concepts in diagnosis and workup of such patients followed by medical, surgical, and liver-directed arterial and ablative therapies. Specific perioperative care for these patients is crucial in avoiding dreaded complications related to Carcinoid Crisis. The recent introduction of Peptide Receptor Radionuclide Therapy as a therapeutic option has impacted some of the algorithms for timing and selection of arterial embolotherapies.